AI vs. radiologists: 150,000 women in landmark breast cancer screening trial
NCT ID NCT06032390
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether artificial intelligence (AI) can help detect breast cancer in mammograms as well as the current standard of two radiologists reading each scan. About 150,000 women in Norway's breast screening program will take part. The goal is to see if AI-assisted reading finds at least as many cancers as the usual double-reading method.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cancer Registry of Norway, Norwegian Institute of Public Health
RECRUITINGOslo, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?